These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 29036000)

  • 1. Unilateral Submandibular Gland Atrophy and Sialolithiasis Diagnosed on 99mTc-MIBI SPECT/CT in a Patient With Primary Hyperparathyroidism.
    Pattanayak P; Santhanam P; Javadi MS; Solnes LB; Rowe SP
    Clin Nucl Med; 2017 Dec; 42(12):939-940. PubMed ID: 29036000
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Beheshti M; Hehenwarter L; Paymani Z; Rendl G; Imamovic L; Rettenbacher R; Tsybrovskyy O; Langsteger W; Pirich C
    Eur J Nucl Med Mol Imaging; 2018 Sep; 45(10):1762-1771. PubMed ID: 29516131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The efficacy of fluorine-18-choline PET/CT in comparison with 99mTc-MIBI SPECT/CT in the localization of a hyperfunctioning parathyroid gland in primary hyperparathyroidism.
    Araz M; Soydal Ç; Özkan E; Kir MK; İbiş E; Güllü S; Erdoğan MF; Emral R; Küçük ÖN
    Nucl Med Commun; 2018 Nov; 39(11):989-994. PubMed ID: 30138157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preoperative ⁹⁹mTc-sestamibi scintigraphy in patients with primary hyperparathyroidism and concomitant nodular goiter: comparison of SPECT-CT, SPECT, and planar imaging.
    Shafiei B; Hoseinzadeh S; Fotouhi F; Malek H; Azizi F; Jahed A; Hadaegh F; Salehian M; Parsa H; Javadi H; Assadi M
    Nucl Med Commun; 2012 Oct; 33(10):1070-6. PubMed ID: 22825041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of 99mTc-sestamibi and 11C-methionine PET/CT in the localization of parathyroid adenomas in primary hyperparathyroidism.
    Martínez-Rodríguez I; Martínez-Amador N; de Arcocha-Torres M; Quirce R; Ortega-Nava F; Ibáñez-Bravo S; Lavado-Pérez C; Bravo-Ferrer Z; Carril JM
    Rev Esp Med Nucl Imagen Mol; 2014; 33(2):93-8. PubMed ID: 24125595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contribution of early SPECT/CT to
    García-Talavera P; Díaz-Soto G; Montes AA; Villanueva JG; Cobo A; Gamazo C; Ruiz MÁ; González-Selma ML
    Rev Esp Med Nucl Imagen Mol; 2016; 35(6):351-357. PubMed ID: 27132216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Virtual neck exploration: a new method for localizing abnormal parathyroid glands.
    Prommegger R; Wimmer G; Profanter C; Sauper T; Sieb M; Kovacs P; Bale R; Putzer D; Gabriel M; Margreiter R
    Ann Surg; 2009 Nov; 250(5):761-5. PubMed ID: 19806053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 11C-methionine PET/CT imaging of 99mTc-MIBI-SPECT/CT-negative patients with primary hyperparathyroidism and previous neck surgery.
    Traub-Weidinger T; Mayerhoefer ME; Koperek O; Mitterhauser M; Duan H; Karanikas G; Niederle B; Hoffmann M
    J Clin Endocrinol Metab; 2014 Nov; 99(11):4199-205. PubMed ID: 25029418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection rate of (99m) Tc-MIBI single photon emission computed tomography (SPECT)/CT in preoperative planning for patients with primary hyperparathyroidism: A meta-analysis.
    Treglia G; Sadeghi R; Schalin-Jäntti C; Caldarella C; Ceriani L; Giovanella L; Eisele DW
    Head Neck; 2016 Apr; 38 Suppl 1():E2159-72. PubMed ID: 25757222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors affecting the sensitivity of Tc-99m methoxyisobutylisonitrile dual-phase parathyroid single photon emission computed tomography in primary hyperparathyroidism.
    Araz M; Çayir D; Erdoğan M; Uçan B; Çakal E
    Nucl Med Commun; 2017 Feb; 38(2):117-123. PubMed ID: 27846041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of calcium channel blockers on the sensitivity of preoperative 99mTc-MIBI SPECT for hyperparathyroidism.
    Friedman K; Somervell H; Patel P; Melton GB; Garrett-Mayer E; Dackiw AP; Civelek AC; Zeiger MA
    Surgery; 2004 Dec; 136(6):1199-204. PubMed ID: 15657576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cystic parathyroid adenoma: Primary hyperparathyroidism without
    Oliver Guillén JR; de la Cueva Barrao L; Miguelena Bobadilla JM; Giménez Maurel T; Hernando Almudí E; Casamayor Franco MC
    Rev Esp Med Nucl Imagen Mol; 2017; 36(4):254-256. PubMed ID: 28392334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual-phase 99mTc sestamibi scintigraphy with neck and thorax SPECT/CT in primary hyperparathyroidism: a single-institution experience.
    Ciappuccini R; Morera J; Pascal P; Rame JP; Heutte N; Aide N; Babin E; Reznik Y; Bardet S
    Clin Nucl Med; 2012 Mar; 37(3):223-8. PubMed ID: 22310246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Four-dimensional computed tomography scan utility in parathyroidectomy for primary hyperparathyroidism with low baseline intact parathyroid hormone.
    Rameau A; Eng S; Vu J; Saket R; Jun P; Friduss M
    Laryngoscope; 2017 Jun; 127(6):1476-1482. PubMed ID: 27515539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rate of Submandibular Gland Atrophy Secondary to Chronic Sialolithiasis.
    Krishnapura SG; Tomblinson CM; Topf MC
    Ear Nose Throat J; 2023 Sep; 102(9):563-565. PubMed ID: 34056944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of SPECT/CT and planar MIBI in terms of operating time and cost in the surgical management of primary hyperparathyroidism.
    Setabutr D; Vakharia K; Nogan SJ; Kamel GN; Allen T; Saunders BD; Goldenberg D
    Ear Nose Throat J; 2015; 94(10-11):448-52. PubMed ID: 26535821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The accuracy of 99m Tc-MIBI scintigraphy for preoperative parathyroid localization in primary and secondary-tertiary hyperparathyroidism.
    Saengsuda Y
    J Med Assoc Thai; 2012 Mar; 95 Suppl 3():S81-91. PubMed ID: 22619892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Planar scintigraphy with 123I/99mTc-sestamibi, 99mTc-sestamibi SPECT/CT, 11C-methionine PET/CT, or selective venous sampling before reoperation of primary hyperparathyroidism?
    Schalin-Jäntti C; Ryhänen E; Heiskanen I; Seppänen M; Arola J; Schildt J; Väisänen M; Nelimarkka L; Lisinen I; Aalto V; Nuutila P; Välimäki MJ
    J Nucl Med; 2013 May; 54(5):739-47. PubMed ID: 23554505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Positive
    Dugonjić S; Šišić M; Radulović M; Ajdinović B
    Hell J Nucl Med; 2017; 20(1):46-50. PubMed ID: 28315908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosis performance of
    Zhou J; Lu DY; Xia L; Cheng XJ
    J Huazhong Univ Sci Technolog Med Sci; 2017 Aug; 37(4):582-586. PubMed ID: 28786065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.